Albendazole and praziquantel

DRUG4 trials

Sponsors

DBL -Institute for Health Research and Development, Universidad Peruana Cayetano Heredia, R-Evolution Worldwide S.r.l. Impresa Sociale, Team Europe Initiative

Conditions

AnaemiaHepatosplenomegalyMalariaNeurocysticercosisSoil Transmitted Helminths

Phase 3

Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)

TerminatedNCT02947581

Universidad Peruana Cayetano HerediaNeurocysticercosis

Start: 2016-11-14End: 2021-02-27Updated: 2022-11-16

MAV+ STH Clinical Trial

RecruitingPACTR202606846629607

Team Europe InitiativeSoil Transmitted Helminths

Start: 2026-06-08Target: 639Updated: 2026-09-14

Phase 4

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

Not yet recruitingNCT06376396

R-Evolution Worldwide S.r.l. Impresa SocialeNeurocysticercosis

Start: 2024-06-30End: 2026-12-31Target: 300Updated: 2024-04-23

Unknown Phase

Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania

CompletedNCT00347113

DBL -Institute for Health Research and DevelopmentAnaemia, Hepatosplenomegaly, Malaria

Start: 2006-07-31End: 2011-01-31Target: 620Updated: 2014-09-23